Coramitug

DB19411InvestigationalProtein Based Therapies

Coramitug: Overview.

Mechanism
Curator reviewed
Also known as
Immunoglobulin G1, anti-(human transthyretin) (human-Mus musculus monoclonal PRX004 γ1-chain), disulfide with human-Mus musculus monoclonal PRX004 κ-chain, dimer
Code names
NNC6019-0001 · PRX-004

Resolves to

Compound
UNII1D57NC901ZCAS2626841-92-5
Targets
P02766TTR

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Coramitug, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In